News & Analysis on Clinical Trial Services & Contract Research And Development
The battle to gain control of the lucrative cholesterol-lowering drug market intensified after Merck and Schering-Plough joined forces to win Food and Drug Administration (FDA) approval for their new entrant, Vytorin.
US researchers have found a delivery method for gene therapy that reaches all the voluntary muscles of a mouse - including heart, diaphragm and limbs - and reverses the process of muscle-wasting found in muscular dystrophy.
The chief executive of leading pharmaceutical company, Astra Zeneca, has issued a bleak warning to European governments: improve the business environment, or we'll take our investment elsewhere.
An antibody drug candidate to treat autoimmune diseases has been exclusively in-licensed by KaloBios Pharmaceuticals who hope to develop this compound into a practicable treatment for rheumatoid arthritis (RA), which currently afflicts one per cent...
A US-based aerosol drug specialist has signed an agreement with Switzerland's Phares Drug Delivery for use of a technology that can improve the delivery of inhalation-therapy drugs and overcome delivery incompatibility in combination products.
Pharmaceutical instrument supplier Argonaut believes its Isolute ppt+ protein precipitation plates can overcome two major obstacles holding back the purity of protein precipitation prior to LC-MS analysis of drugs and metabolites in biological fluids.
Avecia has launched a new precious metal scavenging resin, designed to minimise metal loss and pollution in processing as well as residual metal contamination of a product or intermediates.